Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54


Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy.

Babu KS, Morjaria JB.

Ther Adv Chronic Dis. 2017 Apr;8(4-5):81-91. doi: 10.1177/2040622317700822. Epub 2017 Mar 24. Review.


Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.

Morjaria JB, Rigby A, Morice AH.

Lung. 2017 Jun;195(3):281-288. doi: 10.1007/s00408-017-9990-8. Epub 2017 Mar 3.


Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.

Malerba M, Radaeli A, Montuschi P, Babu KS, Morjaria JB.

Expert Opin Investig Drugs. 2017 Mar;26(3):319-329. doi: 10.1080/13543784.2017.1287172. Epub 2017 Feb 6. Review.


Evidence for harm reduction in COPD smokers who switch to electronic cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Prosperini U, Russo C, Pennisi A, Bruno CM.

Respir Res. 2016 Dec 16;17(1):166.


Blood Pressure Control in Smokers with Arterial Hypertension Who Switched to Electronic Cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Battaglia E, Russo C, Ciampi C, Adams G, Bruno CM.

Int J Environ Res Public Health. 2016 Nov 11;13(11). pii: E1123.


Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes.

Campagna D, Cibella F, Caponnetto P, Amaradio MD, Caruso M, Morjaria JB, Malerba M, Polosa R.

Eur J Clin Invest. 2016 Aug;46(8):698-706. doi: 10.1111/eci.12651. Epub 2016 Jul 8.


Vilanterol trifenatate for the treatment of COPD.

Malerba M, Radaeli A, Montuschi P, Morjaria JB.

Expert Rev Respir Med. 2016 Jul;10(7):719-31. doi: 10.1080/17476348.2016.1184976. Epub 2016 May 25.


Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Caruso M, Campagna D, Amaradio MD, Ciampi G, Russo C, Fisichella A.

Discov Med. 2016 Feb;21(114):99-108.


Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes.

Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, Caruso M, Russo C, Polosa R.

Intern Emerg Med. 2016 Feb;11(1):85-94. doi: 10.1007/s11739-015-1361-y. Epub 2016 Jan 9.


Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.

Babu KS, Morjaria JB.

Ther Adv Respir Dis. 2015 Apr;9(2):56-68. doi: 10.1177/1753465815575254. Epub 2015 Mar 9. Review.


Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.

Prakash A, Babu KS, Morjaria JB.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 7;10:111-23. doi: 10.2147/COPD.S67758. eCollection 2015. Review.


Bilateral chylothorax: an unusual complication of cervical rib resection.

Morjaria JB, Aslam I, Johnson B, Greenstone MA, Kastelik JA.

Ther Adv Chronic Dis. 2015 Jan;6(1):29-33. doi: 10.1177/2040622314552072. Review.


Emerging therapeutic strategies in COPD.

Babu KS, Morjaria JB.

Drug Discov Today. 2015 Mar;20(3):371-9. doi: 10.1016/j.drudis.2014.11.003. Epub 2014 Nov 13. Review.


Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C.

BMC Public Health. 2014 Nov 8;14:1159. doi: 10.1186/1471-2458-14-1159.


Pneumothorax: a tale of pain or spontaneity.

Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA.

Ther Adv Chronic Dis. 2014 Nov;5(6):269-73. doi: 10.1177/2040622314551549. Review.


Is opiate action in cough due to sedation?

Dickinson RS, Morjaria JB, Wright CE, Morice AH.

Ther Adv Chronic Dis. 2014 Sep;5(5):200-5. doi: 10.1177/2040622314543220.


Autonomic dysregulation: a mechanism of asthma death.

Morjaria JB, Rowland T, Tailor P, Hyder S, Wright CE, Hart SP, Morice AH.

Eur Respir J. 2014 Nov;44(5):1357-60. doi: 10.1183/09031936.00076414. Epub 2014 Aug 19. No abstract available.


Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Babu KS, Kastelik JA, Morjaria JB.

Br J Clin Pharmacol. 2014 Aug;78(2):282-300. doi: 10.1111/bcp.12334. Review.


Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD--role of umeclidinium/vilanterol.

Malerba M, Morjaria JB, Radaeli A.

Int J Chron Obstruct Pulmon Dis. 2014 Jun 27;9:687-95. doi: 10.2147/COPD.S47792. eCollection 2014. Review.


Fluticasone furoate and vilanterol for COPD.

Morjaria JB, Morice AH.

Lancet Respir Med. 2013 Jul;1(5):e21. doi: 10.1016/S2213-2600(13)70100-0. Epub 2013 Jul 8. No abstract available.


Supplemental Content

Loading ...
Support Center